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We present the case of a ﬁfteen-year-old male with hypertrophic pyloric stenosis (HPS) thought to have
originated in early infancy when chronic non-bilious emesis, early satiety and failure to thrive were
evident. He developed two episodes of perforated pre-pyloric ulcer at ages 12- and 14-years. Work up for
chronic Helicobacter pylori and Zollinger Ellison syndrome were negative. An upper GI study revealed a
massively enlarged stomach and delayed gastric emptying. Endoscopic ultrasound revealed a thickened
pylorus and a narrow pyloric canal. Electrogastrogram and antroduodenal motility studies supported a
mechanical gastric outlet obstruction. A distal gastrectomy with Billroth I reconstruction was performed.
One year after surgery, the patient’s symptoms resolved and he had gained 14.5 kg in weight. This is a
very rare case of HPS presenting after infancy and emphasizes the importance of early diagnosis of HPS to
prevent long term complications including failure to thrive and death.
Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).While hypertrophic pyloric stenosis (HPS) is a common condi-
tion of infancy that is usually identiﬁed within the ﬁrst 2e4 weeks
of life, it is rare in children after infancy [1,2]. In an older child,
causes of gastric outlet obstruction (GOO) such as primary acquired
GOO, peptic ulcer disease, pyloric stricture (PS) due to granulo-
matous or eosinophilic gastroenteritis, ingestion of caustic sub-
stances, or neoplasia, such as gastrinoma or primary gastric tumors,
must be ruled out in order to diagnose idiopathic HPS [3,4].
In addition, it is important to distinguish HPS of infancy from
late-onset HPS, which has also been described [3].
Herein, we report an atypical presentation of perforated gastric
ulcers in an adolescent with HPS. While HPS in children after
infancy is a rare occurrence, the diagnosis should be considered in
order to identify cases that were not diagnosed early on and pre-
vent long-term complications.1. Case report
1.1. Presentation
A twelve-year-old Caucasian male presented to an outside
hospital following ten days of severe abdominal pain, fever, emesis,C 10-5610, University of New
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ccess article under the CC BY-NCwatery diarrhea and inability to eat or drink. He had a history of
projectile, non-bilious emesis during the ﬁrst month of life. For 3
weeks, his mother fed him formulawith an eyedropper until hewas
able to drink from a bottle with minimal emesis. Throughout his
childhood, he experienced chronic non-bilious emesis, gas bloat,
early satiety, abdominal pain and failure to thrive. He lagged far
behind his fraternal brother on the growth curve.
On presentation to a community hospital, hewas febrile and had
a rigid abdominal wall with rebound tenderness. His white blood
cell count was 13.6  103 cells/mL (N: 4.5e13  103 cells/mL) and he
had an elevated lipase of 620 IU/L (N: 146e200 IU/L) and amylase of
129 IU/L (N: <106 IU/L). He was treated for pancreatitis with bowel
rest and intra-venous ﬂuids. The serum lipase value decreased to
107 IU/L; however, abdominal symptoms progressively worsened.
He was then transferred to our institution to for surgery due to
persistent abdominal pain and rigidity in the face of reductions of
pancreatic enzyme levels.
Upon admission to the hospital, he was febrile to 38.2 C,
tachycardic to 114 beats per minute, and tachypneic at 30 breaths
per minute. On physical examination the patient had peritoneal
signs with a rigid abdominal wall and rebound tenderness. His
hemoglobin (Hgb) was 14.6 g/dL (N: 13e16 g/dL), hematocrit (Hct)
44% (N: 37e49%) and white blood cell count (WBC) was
15.7  103 cells/mL (N: 4.5e13  103 cells/mL). Electrolytes were
within normal limits except for a bicarbonate value of 28 mmol/L
(N: 10e25 mmol/L). Initial amylase and lipase levels were 58 IU/L
and 148 IU/L, respectively. An abdominal ultrasound did not-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Pylorus with muscle hypertrophy with 70 mm 60 mm 50 mm red-white ﬁrm
gelatinous encapsulated nodule abutting the serosal surface. Chromogranin and syn-
aptophysin neuroendocrine markers negative.
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abdominal CT ﬁndings of diffuse bowel thickening, ileus, a large
volume of ﬂuid in the stomach, and pneumoperitoneum were
consistent with peritonitis. Exploratory laparoscopy revealed a
perforated pre-pyloric ulcer that was repairedwith a Graham patch.
After surgery patient was determined to be positive for Helicobacter
pylori (H. pylori) by enzyme immunoassay and was treated with
Metronidazole and Amoxicillin for 3 weeks. Pantoprazole was dis-
continued after 6 weeks. At 8 weeks following surgery, endoscopy
with a biopsy to test for H. pylori was negative and he reported
modest improvement of intestinal symptoms.
Two years later, the patient returned with a contained perfo-
rated pre-pyloric ulcer that was treated with bowel rest, total
parental nutrition (TPN), Pantoprazole, Metoclopramide, and
Piperacillin-Tazobactam for 7 days. An extensive work up was
performed and is described in the investigation below. He was
discharged after 10 days and was tolerating a normal diet. Oral
Lansoprazole was continued for 6 months.
1.2. Investigation
During the patient’s second admission, the Hgb was 14.5 g/dL,
Hct was 43% andWBC was 10.9  103 cells/mL, and gastric pH was 3
(N: 1e3). The serum gastrin value was 79 pg/mL (N: <115 pg/mL)
and the levels of Chromogranin A 70 ng/mL (N: <95 ng/mL),
calcium 9.7 mg/dL (8.4e10.4 mg/dL), and parathyroid hormone
13 pg/mL (N: 111e80 pg/mL) were normal. An abdominal CT
scan did not reveal a pancreatic tumor. Based on these results, a
gastrinoma, carcinoid tumor, and parathyroid etiologies were
excluded.
An upper gastrointestinal contrast study and nuclear gastric
emptying scan indicated delayed gastric emptying.
Esophagogastroduodenoscopy (EGD) with biopsy revealed a
normal esophagus, a large amount of undigested food noted in the
fundus, hyperemic gastric mucosa with normal rugae, scarring at
the pre-pyloric ulcer, a narrow pyloric channel, and normal
duodenal bulb. An endoscopic ultrasound revealed circumferential
thickening of the pyloric muscle resulting in narrowing of the
gastric outlet. An antroduodenal motility study revealed normal
gastro-duodenal motility and excessive intra-gastric pressures
after administration of erythromycin. Collectively, these ﬁndings
suggested a mechanical gastric outlet obstruction due to a hyper-
trophic pyloric muscle.
1.3. Treatment
Seven months after his second admission, an EGD guided Botox
injection into the pylorus produced temporary relief of gastric bloat
and emesis but symptoms gradually recurred. Six months later,
another Botox injection failed to relieve symptoms.
Two weeks after the second Botox injection into the pylorus, he
returned with abdominal pain and emesis due to a gastric wall
abscess in the area of the second pre-pyloric ulcer. He was given
bowel rest, TPN, Ceftriaxone and Metronidazole for 12 days.
Percutaneous aspiration of a gastric wall abscess by interventional
radiologists grew mixed enteric ﬂora. On hospital day 12, he was
discharged home on a full liquid diet and Pantoprazole. A central
line was inserted to continue IV Ceftriaxone andMetronidazole and
provide TPN at home until inﬂammation around the distal stomach
had resolved and surgery could be performed.
Three weeks later, an exploratory laparotomy revealed a thick-
ened, narrow pylorus with scarring around a pseudo-diverticulum
in the area of the contained pre-pyloric perforation. The presence
of the pre-pyloric pseudo-diverticulum and scarring precluded
a pyloroplasty. Therefore, a distal gastrectomy with a Billroth Ireconstructionwas performed. Pathologic examination of the distal
stomach and pylorus conﬁrmed pyloric muscle hypertrophy nega-
tive for neuroendocrine markers, a gastric pseudo-diverticulum
surrounded by scar tissue, and no malignancy (Fig. 1). Following
surgery, he received IV Ceftriaxone and Metronidazole for 3 days
and was discharged home after 8 days.1.4. Outcome and follow-up
At the time of discharge, the patient was able to tolerate a soft,
bland diet. He was sent home on Pantoprazole 40 mg twice daily.
He was gradually advanced to a normal diet. One year after surgery,
he was completely free of nausea, vomiting, early satiety, epigastric
pain, gas bloat or ﬂatulence. He gained 14.5 kg and increased his
weight from the 25th to the 90th percentile.2. Discussion
Hypertrophic pyloric stenosis is a rare cause of gastric outlet
obstruction (GOO) in children and adolescents, though the fre-
quency is unknown [3e5]. Classically, HPS is seen in infants
younger than four months, occurring at a rate of 3e4 in 1000 live
births and presenting with non-bilious emesis and metabolic
alkalosis, which our patient had at presentation [1,2]. Multiple
genetic and environmental risk factors, including early exposure to
macrolide antibiotics, have been associated with infantile HPS
[6e12]. This patient’s only known risk factor for HPS was being a
ﬁrst-born male child. The delay in diagnosis of HPS resulted in
failure to thrive and gastric ulcer perforation with peritonitis. As a
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distal gastrectomy.
Idiopathic HPS has been rarely reported in older children but
consistently presents with projectile, recurrent, and episodic
vomiting as well as weight loss and chronic abdominal pain [3,13].
In addition, several patients have presented with coffee ground
emesis due to gastric ulceration [3]. One case was described in 2013
in which an eight-year-old boy had long standing episodes of non-
bilious emesis and failure to thrive until he was treated with
pyloromyotomy [1]. In contrast, those with late-onset HPS do not
have symptoms in infancy and those with complete GOO are often
diagnosed within one month of development of symptoms
[3,4,13,14]. Similarly, idiopathic primary acquired GOO, also known
as Jodhpur disease, as described in 1997 by Sharma et al., is distinct
fromHPS in that the pylorus is normal, lacks muscular hypertrophy,
and does not consistently present with symptoms in infancy. Pri-
mary acquired GOO is rare and the etiology is not yet known
[3,4,15].
Considering the rarity of idiopathic HPS in older children, other
causes of GOO should be investigated. The initial work up for GOO
should ﬁrst aim to rule out more common diagnoses, such as
acute or chronic pancreatitis, biliary obstruction, appendicitis, and
thyroid dysfunction. All of these conditions were ruled out in our
patient.
Pyloric stricture (PS) may present similarly to HPS and is seen
more commonly in the adolescent patient [3]. A pyloric stricture in
the older child may be due to peptic ulcer disease, ulceration from
gastrinoma or autoimmune disease, primary gastric neoplasia
including carcinoma and lymphoma, granulomatous diseases,
eosinophilic gastroenteritis, amyloidosis, ingestion of caustic sub-
stances, or iatrogenic causes [3,4,16]. Diagnosis of PS is based pri-
marily on the patient’s history and associated symptoms.
Endoscopically guided biopsy with histological analysis may di-
agnose or exclude eosinophilia, amyloidosis, granulomatous dis-
ease, or neoplasia, while anti-nuclear antibodies and rheumatoid
factor may rule out autoimmune processes. Hypertrophy of the
pyloric muscle detected on abdominal ultrasound with HPS is not
seen with PS [17,18].
Our patient had symptoms highly suggestive of HPS during the
ﬁrst month of life. Persistent emesis and failure to thrive
throughout childhood suggests a chronic partial gastric outlet
obstruction that began during infancy, such as HPS. It is unclear
why a surgical evaluationwas not performed during infancy or why
the HPS did not resolve spontaneously. If left untreated, mortality of
HPS is high. The frequency of spontaneous resolution of HPS inmild
cases is unknown [2,19].
Perforation of a gastric ulcer is also an uncommon event in
children, however, possible causes include chronic H. pylori
gastritis, gastrinoma causing Zollinger-Ellison (ZE) syndrome,
ingestion of caustic substances or foreign bodies, primary gastric
neoplasia, and iatrogenic causes, such as chronic steroid or NSAID
use or instrumentation [20e22]. While no correlation has been
reported between H. Pylori and HPS in the literature, an H. Pylori
infection superimposed on impaired gastric emptying and
increased gastric pressure may have caused gastric ulceration and
perforation in our patient. However, the gastrointestinal tract is not
yet colonized by bacteria until after infancy and, therefore, chronic
gastritis alone cannot account for his early symptoms [3,18,23]. In
this patient, a normal gastric pH while not receiving antacids,
normal gastrin levels and an EGD without classic gastric hyper-
trophic mucosa rugae eliminated ZE syndrome as the etiology for a
perforating gastric ulcer [20,21]. In addition, he had no history of
iatrogenic exposure such as esophageal dilatation or endoscopy
and histopathology of gastric mucosa excluded other causes such as
gastritis and connective tissue or autoimmune diseases.Endoscopic injection of botulinum toxin A (Botox) into the
pyloric has not been shown to be an effective treatment option in
HPS. Unlike esophageal achalasia, a condition that responds to
Botox injection, release of acetylcholine is not impaired in HPS [12].
This patient received Botox injection before HPS was identiﬁed
on ultrasound. A second Botox injection was requested by the
family to alleviate symptoms and attend a family event prior to
surgery.
The Ramstedt pyloromyotomy, ﬁrst described in 1912, is the
standard treatment for infantile HPS [2,19].
Alternative procedures such as gastroduodenostomy (Billroth I)
or gastrojejunostomy (Billroth II) have been utilized in patients
with peptic ulcer induced gastric outlet obstruction. Pylo-
romyotomy or pyloroplasty were considered in this patient
[3,20,24]. However, the presence of a gastric pseudo-diverticulum
and scaring in the distal stomach from recurrent perforated ulcers
required a Billroth I to restore gastric emptying.3. Conclusion
We present an unusual case of a 15-year-old male who had
symptoms of a partial gastric outlet obstruction since infancy and
developed a perforated gastric ulcer. Exploratory laparotomy
revealed hypertrophic pyloric stenosis that likely persisted since
infancy. Symptoms were relieved at age 15 years by a distal
gastrectomy and Billroth I reconstruction. This case presentation
underscores the importance of early identiﬁcation and surgical
treatment of HPS in order to avoid chronic symptoms, failure to
thrive, more extensive surgery and greater morbidity andmortality.References
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